Digital Screening for Atrial Fibrillation to Prevent Stroke
NCT: NCT07684053 · RECRUITING
Brief Summary
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
Frequently Asked Questions
What is Digital Screening for Atrial Fibrillation to Prevent Stroke?
Digital Screening for Atrial Fibrillation to Prevent Stroke is a clinical trial registered under NCT07684053. Current status: RECRUITING.
What is the status of NCT07684053?
The current status of NCT07684053 (Digital Screening for Atrial Fibrillation to Prevent Stroke) is: RECRUITING.
When did Digital Screening for Atrial Fibrillation to Prevent Stroke start?
Digital Screening for Atrial Fibrillation to Prevent Stroke started on 2026-06-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.